Altimmune, Inc. (FRA:3G0)
Germany flag Germany · Delayed Price · Currency is EUR
4.500
+0.160 (3.69%)
At close: Jan 30, 2026

Altimmune Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-83.92-95.06-88.45-84.71-97.09-49.04
Depreciation & Amortization
0.120.240.480.490.550.43
Other Amortization
0.17-----
Asset Writedown & Restructuring Costs
--12.42-11.95-
Loss (Gain) From Sale of Investments
-2.13-3.85-2.47-0.7--
Stock-Based Compensation
14.4914.3910.648.15.522.58
Other Operating Activities
-0.68-0.05-0.150.121.0816.25
Change in Accounts Receivable
-0.420.57-0.940.264.18-3.59
Change in Accounts Payable
3.67-1.86-2.732.771.420.59
Change in Income Taxes
3.051.17-1.373.042.35-7.13
Change in Other Net Operating Assets
-0.74.6-3.238.04-8.215.62
Operating Cash Flow
-66.35-79.85-75.81-62.59-78.24-34.31
Capital Expenditures
-0.01--0.05-0.13-12.12-0.2
Sale (Purchase) of Intangibles
-----0.2-0.14
Investment in Securities
-39.67-28.3913.78-73.2799.84-71.88
Investing Cash Flow
-39.68-28.3913.73-73.487.52-72.23
Short-Term Debt Issued
-----0.63
Total Debt Issued
15----0.63
Short-Term Debt Repaid
------0.63
Total Debt Repaid
------0.63
Net Debt Issued (Repaid)
15-----
Issuance of Common Stock
122.5110.8986.9357.365.22213.49
Repurchase of Common Stock
-0.69-0.85-0.54-0.52--
Other Financing Activities
-1.02--0.29--0.12-
Financing Cash Flow
135.810.0486.1156.7865.1213.49
Net Cash Flow
29.76-98.1924.03-79.274.38106.96
Free Cash Flow
-66.36-79.85-75.86-62.71-90.36-34.51
Free Cash Flow Margin
-331810.00%-399240.00%-17806.81%--2048.87%-421.62%
Free Cash Flow Per Share
-0.83-1.13-1.43-1.34-2.19-1.35
Cash Interest Paid
0.46----0
Levered Free Cash Flow
-37.67-44.87-49.98-41.69-52.56-25.61
Unlevered Free Cash Flow
-37.2-44.86-49.96-41.69-52.56-25.6
Change in Working Capital
5.64.48-8.2714.11-0.25-4.51
Source: S&P Global Market Intelligence. Standard template. Financial Sources.